| Literature DB >> 29545775 |
Julia Fernandez Puñal de Araújo1, Priscila Lang Podratz1, Eduardo Merlo1, Isabela Valim Sarmento1, Charles Santos da Costa1, Oscar Mauricio Santamaria Niño1, Rodrigo Alves Faria1, Leandro Ceotto Freitas Lima1, Jones Bernardes Graceli1.
Abstract
Organotin (OTs) compounds are organometallic compounds that are widely used in industry, such as in the manufacture of plastics, pesticides, paints, and others. OTs are released into the environment by anthropogenic actions, leading to contact with aquatic and terrestrial organisms that occur in animal feeding. Although OTs are degraded environmentally, reports have shown the effects of this contamination over the years because it can affect organisms of different trophic levels. OTs act as endocrine-disrupting chemicals (EDCs), which can lead to several abnormalities in organisms. In male animals, OTs decrease the weights of the testis and epididymis and reduce the spermatid count, among other dysfunctions. In female animals, OTs alter the weights of the ovaries and uteri and induce damage to the ovaries. In addition, OTs prevent fetal implantation and reduce mammalian pregnancy rates. OTs cross the placental barrier and accumulate in the placental and fetal tissues. Exposure to OTs in utero leads to the accumulation of lipid droplets in the Sertoli cells and gonocytes of male offspring in addition to inducing early puberty in females. In both genders, this damage is associated with the imbalance of sex hormones and the modulation of the hypothalamic-pituitary-gonadal axis. Here, we report that OTs act as reproductive disruptors in vertebrate studies; among the compounds are tetrabutyltin, tributyltin chloride, tributyltin acetate, triphenyltin chloride, triphenyltin hydroxide, dibutyltin chloride, dibutyltin dichloride, diphenyltin dichloride, monobutyltin, and azocyclotin.Entities:
Keywords: endocrinology; environmental pollutants; organotin compounds; reproduction; vertebrates
Year: 2018 PMID: 29545775 PMCID: PMC5838000 DOI: 10.3389/fendo.2018.00064
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Summary of vertebrate reproductive changes induced by OTs.
| Animal models/dose/OTs | |||||||
|---|---|---|---|---|---|---|---|
| Fish | Frog | Rodents | Monkey | Reference | |||
| (0.01–25 µg/kg) | (0.5 µg to 0.5 g/L) | (100 ng to 125 mg/kg) | (2.5–3.8 mg/kg) | ||||
| TriOTs | Azocyclotin | Azocyclotin | TriOTs | DiOTs | DiOTs | ||
| Organ weights (g/bw) | |||||||
| Testes, epididymis | NR | NR | NR | ↓ | NR | NR | ( |
| Prostate, seminal vesicle | NR | NR | NR | ↓ | NR | NR | ( |
| Sn accumulation | NR | NR | NR | ↑ | NR | NR | ( |
| Histopathology | |||||||
| Spermatocytes/spermatids | NR | ↑ | NR | ↓ | NR | NR | ( |
| Sperm viability/number | ↓ | ↓ | NR | ↓ | NR | NR | ( |
| Seminiferous tubules | NR | NR | NR | ↑/↓ Lumen | NR | NR | ( |
| Testes | Fibrosis | NR | NR | Edema | NR | NR | ( |
| Leidig cells (number) | NR | NR | NR | ↓ | NR | NR | ( |
| Sex hormones | ↓ FSH | NR | ↑ T | ↑/↓ LH, ↓ T | NR | NR | ( |
| Cryptorchidism | NA | NA | NA | ↔ | NR | NR | ( |
| Preputial separation | NA | NA | NA | ↔ | NR | NR | ( |
| Testes, epididymis and prostate weight | NA | NA | NA | ↓/↔ | NR | NR | ( |
| Gonocytes, Sertoli cells (number) | NA | NA | NA | ↓ | NR | NR | ( |
| Spermatid and sperm (number) | NA | NA | NA | ↓ | NR | NR | ( |
| Sperm motility | NA | NA | NA | ↓/↔ | NR | NR | ( |
| Sex hormones | NA | NA | NA | ↑T, ↑LH, ↓E2 | NR | NR | ( |
| Estrous cyclicity | NR | NR | NR | Impaired | NR | NR | ( |
| Ovary weight (g/bw) | NR | ↓ | ↓ | ↓/↑ | NR | NR | ( |
| Sn accumulation | NR | NR | NR | ↑ | NR | NR | ( |
| Histopathology | |||||||
| Ovarian follicles | NR | NR | NR | ↑ Apoptosis, ↑ Atretic | NR | NR | ( |
| Folliculogenesis | NR | Impaired | NR | ↓ Mature follicles | NR | NR | ( |
| Sex hormones | NR | ↑T, ↓E2 | NR | ↑/↓ E2, ↑T | NR | NR | ( |
| Vaginal opening | NA | NA | NA | ↑/↓ | NR | NR | ( |
| Estrous cyclicity | NA | NA | NA | Impaired | NR | NR | ( |
| Ovary morphology | NA | NA | NA | Impaired | NR | NR | ( |
| Loss pre- and postimplantation | NR | NR | NR | ↑ | ↑ | ↑ | ( |
| Number of live fetuses | ↓ | NR | NR | ↑ | NR | NR | ( |
| Sex ratio (female/male) | ↔/↑/↓ | NR | NR | ↔ | NR | ↔ | ( |
| Litter size | NR | NR | NR | ↓/↔ | NR | NR | ( |
| Hatchability/egg viability | ↔/↓ | NR | NR | NR | NR | NR | ( |
OTs, organotins; TriOTs, triorganotins (tributyltin chloride, tributyltin acetate, triphenyltin chloride, triphenyltin hydroxide); DiOTs, diorganotins (dibutyltin chloride, dibutyltin dichloride, diphenyltin dichloride); Sn, tin; ↑, increased; ↓, decreased; ↔, unchanged or similar to control; NR, not reported; NA, not applicable; bw, body weight; LH, luteinizing hormone; T, testosterone; FSH, follicle-stimulating hormone; E2, estrogen; Fish, zebrafish (Danio rerio), rockfish (Sebastiscus marmoratus), and Oryzia latipes; frog, Xenopus laevis, Rodents, rats and mice; monkey, Macaca fascicularis.
Summary of placental changes induced by OTs.
| Animal models/dose/OTs | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rodents | Human | JAr and JEG-3 cells | Reference | |||||||
| (100 ng to 125 mg/kg) | (0.25–20 mg/kg or 6.2 µM) | (1–100 nM) | ||||||||
| TriOTs | DiOTs | TriOTs | DiOTs | TeBT | MBT | TriOTs | DiOTs | MBT | ||
| Sn accumulation | ↑ | NR | ↑ | NR | NR | ↑ | NR | NR | NR | ( |
| Aromatase activity | NR | NR | ↓ | ↓ | ↔ | ↔ | ↑ | ↑/↔ | NR | ( |
| 3β-HSD activity | NR | NR | ↓ | ↔ | ↔ | ↔ | NR | NR | NR | ( |
| hCG secretion | NR | NR | NR | NR | NR | NR | ↑ | ↑/↔ | NR | ( |
| RXR activation | NR | NR | NR | NR | NR | NR | ↑ | NR | NR | ( |
| 17β-HSD I activity | NR | NR | NR | NR | NR | NR | ↑ | ↑ | NR | ( |
| Progesterone | NR | NR | NR | NR | NR | NR | ↑ | ↑ | ↑ | ( |
OTs, organotins; TriOTs, triorganotins (tributyltin chloride, tributyltin acetate, triphenyltin chloride, triphenyltin hydroxide); DiOTs, diorganotins (dibutyltin chloride, dibutyltin dichloride, diphenyltin dichloride); TeBT, tetrabutyltin; MBT, monobutyltin; Sn, tin; ↑, increased; ↓, decreased; ↔, unchanged or similar to control; NR, not reported; Rodents, rats and mice; Human, placenta samples were obtained as reported in Ref. (.